**4. Acknowledgements**

This work was partly supported by the R&D Program of MKE/KEIT (10035333, Development of anti-cancer therapeutic agent based on regulating cell cycle or cell death) as well as by the National Research Foundation (NRF-2011-0000380), Ministry of Education, Science and Technology (MEST) in Korea.
